VYNE

Conviction 80HealthcareScan · Mon, Aug 10, 2026

VYNE$28.56+5511.00%

ResistanceSupportVol 14

Vol MA14 2.73M

Apr 27May 13Jun 2Jun 18Jul 9Jul 27

Yarrow Bioscience, Inc.PHARMACEUTICAL PREPARATIONSwww.vynetherapeutics.com ↗

Price28.56

Change+5511.00%

Gap+4909.82%

Rel volume0.05×

Avg volume1.98M

Avg $ vol1.54M

SMA 202.11

SMA 501.24

SMA 2000.7029

Price vs 50+2200.90%

Price vs 200+3962.97%

MA stackbullish

50/200 cross—

Supertrendup · 17.28

RSI (14)99

MACD hist1.77

MACD crossbull · 0d

Stoch %K / %D100 / 68

ADX (14)37

+DI / −DI97 / 1

RSI divergence—

MACD divergenceBullish

ATR %+7.28%

ADR %7.69%

52w high28.56

52w low0.2870

From 52w high+0.00%

Above 52w low+9851.22%

New 52w highYes

SqueezeOff

Bollinger width1150.45%

%B1.59

Donchian pos100.00%

Donchian high28.56

Donchian low0.4700

AVWAP (52w high)26.83

vs AVWAP high+6.45%

AVWAP (52w low)0.5664

vs AVWAP low+4942.41%

OBV trendFlat

Chaikin MF (20)0.28

Today vs 20d0.05×

Avg vol (14d)2.73M

Avg vol (20d)1.98M

Avg $ vol (20d)1.54M

Market cap952.56M

RS 3m (vs SPY)+4323.70%

RS 6m (vs SPY)+4812.66%

RS line new highYes

Trend template8/8

Technical rank99.9

1 week+3435.53%

1 month+4282.38%

3 months+4327.22%

6 months+4819.90%

1 year+2031.34%

YTD+4824.99%

P/E-35.97

P/B38.66

P/S—

P/FCF-28.76

EPS-0.6200

Div yield—

ROE-107.49%

ROA-102.36%

Debt/Eq0.00

Current20.86

EV/EBITDA-31.22

Gross margin—

Net margin—

Rev growth13.77%

EPS growth33.52%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value927.93M

Revenue86K

Net income-3.58M

Gross profit—

Free cash flow-33.12M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out33.35M

Employees10

ListedThu, Jan 25, 2018

Free float31.6M

Float %94.8%

Short interest183.97K

Days to cover0.1d

Short volume—

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank99.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.6924

Support0.6111

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VYNE

All disclosures →

No recent disclosed trades by Congress in VYNE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VYNE · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Domzalski David PRESIDENT AND CEO · Common Stock · 2026-05-29	Grant	30.79K	$10K	2026-05-29	2026-06-02

SEC filings

EDGAR filings in VYNE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.